Ivivi Technologies Competitors

Ivivi Technologies (OTCMKTS:IVVI) and Medtronic (NYSE:MDT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Medtronic, as reported by MarketBeat.com.

Medtronic has a consensus target price of $124.2692, suggesting a potential upside of 0.30%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Ivivi Technologies.

Profitability

This table compares Ivivi Technologies and Medtronic's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Ivivi Technologies and Medtronic's revenue, earnings per share and valuation.

Medtronic has higher revenue and earnings than Ivivi Technologies.

Institutional and Insider Ownership

79.2% of Medtronic shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Comparatively, 0.5% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Medtronic beats Ivivi Technologies on 8 of the 9 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Sonova, as reported by MarketBeat.com.

Profitability

This table compares Ivivi Technologies and Sonova's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Ivivi Technologies and Sonova's revenue, earnings per share and valuation.

Sonova has higher revenue and earnings than Ivivi Technologies.

Institutional and Insider Ownership

1.1% of Sonova shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Sonova beats Ivivi Technologies on 3 of the 4 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Institutional and Insider Ownership

87.0% of Varian Medical Systems shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by insiders. Comparatively, 0.8% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Varian Medical Systems' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings for Ivivi Technologies and Varian Medical Systems, as reported by MarketBeat.com.

Varian Medical Systems has a consensus target price of $159.3571, suggesting a potential downside of 10.00%. Given Varian Medical Systems' higher possible upside, analysts plainly believe Varian Medical Systems is more favorable than Ivivi Technologies.

Earnings & Valuation

This table compares Ivivi Technologies and Varian Medical Systems' revenue, earnings per share and valuation.

Varian Medical Systems has higher revenue and earnings than Ivivi Technologies.

Summary

Varian Medical Systems beats Ivivi Technologies on 6 of the 7 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

81.6% of Masimo shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Comparatively, 11.5% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Masimo's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and Masimo, as reported by MarketBeat.

Masimo has a consensus target price of $272.20, suggesting a potential upside of 13.63%. Given Masimo's higher possible upside, analysts clearly believe Masimo is more favorable than Ivivi Technologies.

Earnings and Valuation

This table compares Ivivi Technologies and Masimo's revenue, earnings per share and valuation.

Masimo has higher revenue and earnings than Ivivi Technologies.

Summary

Masimo beats Ivivi Technologies on 7 of the 8 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and Getinge (OTCMKTS:GNGBY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

0.0% of Getinge shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and Getinge's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and Getinge, as reported by MarketBeat.

Earnings and Valuation

This table compares Ivivi Technologies and Getinge's revenue, earnings per share and valuation.

Getinge has higher revenue and earnings than Ivivi Technologies.

Summary

Getinge beats Ivivi Technologies on 6 of the 7 factors compared between the two stocks.

Ivivi Technologies (OTCMKTS:IVVI) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Institutional & Insider Ownership

89.1% of LivaNova shares are held by institutional investors. 31.2% of Ivivi Technologies shares are held by company insiders. Comparatively, 0.5% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ivivi Technologies and LivaNova's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for Ivivi Technologies and LivaNova, as reported by MarketBeat.

LivaNova has a consensus target price of $69.3333, suggesting a potential downside of 14.79%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than Ivivi Technologies.

Earnings and Valuation

This table compares Ivivi Technologies and LivaNova's revenue, earnings per share and valuation.

Ivivi Technologies has higher earnings, but lower revenue than LivaNova.

Summary

LivaNova beats Ivivi Technologies on 6 of the 8 factors compared between the two stocks.